{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:27Z","timestamp":1791389127382,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2020059"],"award-info":[{"award-number":["2020059"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Barbra Streisand Women\u2019s Cardiovascular Research and Education Program"},{"name":"Linda Joy Pollin Women\u2019s Heart Health Program"},{"name":"Erika Glazer Women\u2019s Heart Health Project"},{"name":"Walter R. Ferguson Charitable Fund"},{"DOI":"10.13039\/100017007","name":"Adelson Family Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017007","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-022-02546-7","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T13:02:46Z","timestamp":1643806966000},"page":"1579-1586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Subclinical hepatic fibrosis is associated with coronary microvascular dysfunction by myocardial perfusion reserve index: a retrospective cohort study"],"prefix":"10.1007","volume":"38","author":[{"given":"Alan C.","family":"Kwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerran","family":"Salto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor-Trung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Botting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Noel Bairey","family":"Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4977-036X","authenticated-orcid":false,"given":"Susan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"issue":"5","key":"2546_CR1","first-page":"1131","volume":"26","author":"M Pozzi","year":"1997","unstructured":"Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S et al (1997) Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 26(5):1131\u20131137","journal-title":"Hepatology"},{"key":"2546_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","volume":"5","author":"S Mitra","year":"2020","unstructured":"Mitra S, De A, Chowdhury A (2020) Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol 5:16","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"6","key":"2546_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","volume":"41","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Perseghin G (2021) Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int 41(6):1290\u20131293","journal-title":"Liver Int"},{"issue":"7","key":"2546_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J, Sanyal A, Neuschwander-Tetri B, Tiribelli C et al (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158(7):1999-2014.e1","journal-title":"Gastroenterology"},{"issue":"1","key":"2546_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M et al (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67(1):328\u2013357","journal-title":"Hepatology"},{"issue":"7","key":"2546_CR6","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, K\u00fctting F, Goeser T, Demir M et al (2021) NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol 110(7):921\u2013937","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"2546_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1148\/radiol.2019190264","volume":"291","author":"B Ambale-Venkatesh","year":"2019","unstructured":"Ambale-Venkatesh B, Lima JA (2019) Probing the liver\u2013heart axis. Radiology 291(2):338\u2013339","journal-title":"Radiology"},{"key":"2546_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3389\/fmed.2019.00202","volume":"6","author":"A Ismaiel","year":"2019","unstructured":"Ismaiel A, Dumitra\u015fcu DL (2019) Cardiovascular risk in fatty liver disease: the liver\u2013heart axis\u2014literature review. Front Med 6:202","journal-title":"Front Med"},{"issue":"4","key":"2546_CR9","doi-asserted-by":"publisher","first-page":"e002481","DOI":"10.1161\/CIRCIMAGING.114.002481","volume":"8","author":"LE Thomson","year":"2015","unstructured":"Thomson LE, Wei J, Agarwal M, Haft-Baradaran A, Shufelt C, Mehta PK et al (2015) Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction: a National Heart, Lung, and Blood Institute-sponsored study from the Women\u2019s Ischemia Syndrome Evaluation. Circ Cardiovasc Imaging 8(4):e002481","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"2546_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1148\/radiology.211.3.r99jn41698","volume":"211","author":"A Hk","year":"1999","unstructured":"Hk A, Saeed M, Higgins CB, Gao D-W, Bremerich J, Wyttenbach R et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211(3):698\u2013708","journal-title":"Radiology"},{"issue":"1","key":"2546_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1532-429X-12-65","volume":"12","author":"AM Maceira","year":"2010","unstructured":"Maceira AM, Cos\u00edn-Sales J, Roughton M, Prasad SK, Pennell DJ (2010) Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 12(1):1\u201310","journal-title":"J Cardiovasc Magn Reson"},{"issue":"3","key":"2546_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jcmg.2020.09.034","volume":"14","author":"W Zhou","year":"2021","unstructured":"Zhou W, Lee JCY, Leung ST, Lai A, Lee T-F, Chiang JB et al (2021) Long-term prognosis of patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance. JACC Cardiovasc Imaging 14(3):602\u2013611","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"2546_CR13","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","volume":"71","author":"A Srivastava","year":"2019","unstructured":"Srivastava A, Gailer R, Tanwar S, Trembling P, Parkes J, Rodger A et al (2019) Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J Hepatol 71(2):371\u2013378","journal-title":"J Hepatol"},{"issue":"3","key":"2546_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/MEG.0000000000001519","volume":"32","author":"MA de Carli","year":"2020","unstructured":"de Carli MA, de Carli LA, Correa MB, Junqueira G Jr, Tovo CV, Coral GP (2020) Performance of noninvasive scores for the diagnosis of advanced liver fibrosis in morbidly obese with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 32(3):420\u2013425","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"2546_CR15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/hep.30842","volume":"70","author":"QM Anstee","year":"2019","unstructured":"Anstee QM, Lawitz EJ, Alkhouri N, Wong VWS, Romero-Gomez M, Okanoue T et al (2019) Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials. Hepatology 70(5):1521\u20131530","journal-title":"Hepatology"},{"issue":"10","key":"2546_CR16","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cgh.2019.12.026","volume":"18","author":"F Baratta","year":"2020","unstructured":"Baratta F, Pastori D, Angelico F, Balla A, Paganini AM, Cocomello N et al (2020) Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study. Clin Gastroenterol Hepatol 18(10):2324\u201331.e4","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2546_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","volume":"155","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M et al (2018) Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology 155(2):443\u201357.e17","journal-title":"Gastroenterology"},{"issue":"7","key":"2546_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/apt.15660","volume":"51","author":"JB Henson","year":"2020","unstructured":"Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE (2020) Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 51(7):728\u2013736","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2546_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.20781","volume":"42","author":"N Villanova","year":"2005","unstructured":"Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E et al (2005) Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42(2):473\u2013480","journal-title":"Hepatology"},{"issue":"3","key":"2546_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/hep.27869","volume":"62","author":"LB VanWagner","year":"2015","unstructured":"VanWagner LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, Carr JJ, Lima JA et al (2015) Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 62(3):773\u2013783","journal-title":"Hepatology"},{"issue":"6","key":"2546_CR21","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1007\/s10620-009-0935-9","volume":"55","author":"C-H Chen","year":"2010","unstructured":"Chen C-H, Nien C-K, Yang C-C, Yeh Y-H (2010) Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci 55(6):1752\u20131760","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2546_CR22","doi-asserted-by":"publisher","first-page":"e000598","DOI":"10.1136\/openhrt-2017-000598","volume":"4","author":"Y Sato","year":"2017","unstructured":"Sato Y, Yoshihisa A, Kanno Y, Watanabe S, Yokokawa T, Abe S et al (2017) Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. Open Heart 4(1):e000598","journal-title":"Open Heart"},{"issue":"2","key":"2546_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pcad.2020.02.010","volume":"63","author":"KA So-Armah","year":"2020","unstructured":"So-Armah KA, Lim JK, Re VL III, Tate JP, Chang C-CH, Butt AA et al (2020) FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C. Prog Cardiovasc Dis 63(2):184\u2013191","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"2546_CR24","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jamacardio.2021.1825","volume":"6","author":"CJ Rush","year":"2021","unstructured":"Rush CJ, Berry C, Oldroyd KG, Rocchiccioli JP, Lindsay MM, Touyz RM et al (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiol 6(10):1130\u20131143","journal-title":"JAMA Cardiol"},{"issue":"37","key":"2546_CR25","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","volume":"39","author":"SJ Shah","year":"2018","unstructured":"Shah SJ, Lam CS, Svedlund S, Saraste A, Hage C, Tan R-S et al (2018) Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 39(37):3439\u20133450","journal-title":"Eur Heart J"},{"issue":"10","key":"2546_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","volume":"39","author":"VR Taqueti","year":"2018","unstructured":"Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT et al (2018) Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J 39(10):840\u2013849","journal-title":"Eur Heart J"},{"issue":"2","key":"2546_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1148\/radiol.2019181793","volume":"291","author":"T Vita","year":"2019","unstructured":"Vita T, Murphy DJ, Osborne MT, Bajaj NS, Keraliya A, Jacob S et al (2019) Association between nonalcoholic fatty liver disease at CT and coronary microvascular dysfunction at myocardial perfusion PET\/CT. Radiology 291(2):330\u2013337","journal-title":"Radiology"},{"issue":"9","key":"2546_CR28","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1253\/circj.CJ-11-1487","volume":"76","author":"S Nakamori","year":"2012","unstructured":"Nakamori S, Onishi K, Nakajima H, Yoon YE, Nagata M, Kurita T et al (2012) Impaired myocardial perfusion reserve in patients with fatty liver disease assessed by quantitative myocardial perfusion magnetic resonance imaging. Circ J 76(9):2234\u20132240","journal-title":"Circ J"},{"issue":"17","key":"2546_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","volume":"35","author":"F Crea","year":"2014","unstructured":"Crea F, Camici PG, Bairey Merz CN (2014) Coronary microvascular dysfunction: an update. Eur Heart J 35(17):1101\u20131111","journal-title":"Eur Heart J"},{"issue":"1","key":"2546_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-69013-y","volume":"10","author":"A Miller","year":"2020","unstructured":"Miller A, McNamara J, Hummel SL, Konerman MC, Tincopa MA (2020) Prevalence and staging of non-alcoholic fatty liver disease among patients with heart failure with preserved ejection fraction. Sci Rep 10(1):1\u20139","journal-title":"Sci Rep"},{"issue":"2","key":"2546_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM et al (2021) Prognostic accuracy of Fib-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int 41(2):261\u2013270","journal-title":"Liver Int"},{"issue":"9","key":"2546_CR32","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E, Burt AD, Day CP (2010) Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 59(9):1265\u20131269","journal-title":"Gut"},{"issue":"9","key":"2546_CR33","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/hepr.12647","volume":"46","author":"W Sun","year":"2016","unstructured":"Sun W, Cui H, Li N, Wei Y, Lai S, Yang Y et al (2016) Comparison of FIB-4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non-alcoholic fatty liver disease: a meta-analysis study. Hepatol Res 46(9):862\u2013870","journal-title":"Hepatol Res"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-022-02546-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02546-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T09:41:43Z","timestamp":1717148503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-022-02546-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["2546"],"URL":"https:\/\/doi.org\/10.1007\/s10554-022-02546-7","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr, Merz serves on the Board of Directors for iRhythm and has received fees paid through Cedars-Sinai Medical Center from Abbott Diagnostics and Sanofi. Dr. Wei has served on an advisory board for Abbott Vascular. The other authors report no relevant conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Study was approved by Cedars Sinai IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent waived due to retrospective study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}